Clinical trial
A Phase II Pilot Study of Dovitinib (TKI258) in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
NCT01524692 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Pilot Study of Dovitinib (TKI258) in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
- Lead sponsor
- University of Virginia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenoid cystic carcinoma